By binding to specific receptors such as FPR1, N-formylphenylalanine can modulate immune cell activity and reduce inflammatory responses, helping to lower the risk of various cancers (Tennenberg et al., 1988; Snapkov et al., 2016). This evidence concerns the gene FPR1 and cancer.